A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause ...
The second module submitted earlier this week for the RefluxStoptm PMA is the most crucial module of the three-module process for FDA approval. The outcome of our clinical study submitted to FDA shows ...
A primary benefit of the FDA Fast Track designation is how it accelerates the drug approval process. Early and continuous ...
BEDFORD, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world through ...
From the BBC World Service: The Labour Party's budget includes a $50 billion tax hike to fund public services. Our weekly “Econ Extra Credit” newsletter is an unexpected way to learn about the ...
The FDA approved mifepristone in 2000 and GenBioPro’s generic version in 2019. Abortion opponents have repeatedly challenged regulations to and the approval of the drug. In June, the Supreme ...
Try Lizzo!” and “Lose guilt, gain confidence.” The photo, which features the pop-rap phenom in a “FDA-approved” medicine carton cinched with a tape measure, includes various disclaimers ...
The agency updates and modifies the alerts as needed. Recent modifications to FDA’s import alerts, as posted by the agency, are listed below. Use the chart below to view import alerts.
Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...
2024 Healthcare & Pharmaceuticalscategory US FDA approves Johnson & Johnson's device for heart condition November 7, 2024 Healthcare & Pharmaceuticalscategory Americans hungry for weight-loss ...
Sulopenem, which will now go by the commercial moniker Orlynvah, was approved by the FDA Friday to treat uncomplicated urinary tract infections (uUTIs) caused by E. coli, Klebsiella pneumoniae or ...